MAPK3 and cancer: Under certain conditions, ER stress can also promote MAPK signaling, including ERK1/2, which can be a pro-cancer signal, which makes inhibiting UPRER a potential therapeutic intervention for these cancers (Jiang et al., 2007; Beck et al., 2013).